Abstract
On exposure to maturation stimuli, immature dendritic cells (DCs) undergo changes that turn them into potent amplifiers of innate immunity and into antigen-presenting cells (APCs) able to prime naïve T cells. However, their progression through the maturation process is very rapid and finally ends in apoptosis. The aim of our study was to investigate the importance of the maturation stage of DCs, defined by morphology, expression of surface markers and IL-12 production, for their immunostimulatory capacity. DCs were matured with LPS, monocyte-conditioned medium (MCM) or TNF-alpha, sampled several times during a 3-day long maturation period and used as stimulators of allogeneic T cells over a wide range of DC/T cell ratios. T-cell response was assessed by cell proliferation, CTL generation and IFN-gamma production. Our results indicate that the in vitro T cell response is determined mainly by the level of expression of co-stimulatory molecules on DCs and the DC/T cell ratio in the culture. Thus, DCs matured for over 20h, with high expression of co-stimulatory molecules, can still induce a potent CTL response at DC/T cell ratios of 1:10 and 1:20, although their IL-12 production, as well as their ability to induce IFN-gamma product...Continue Reading
References
Aug 1, 1992·Cellular Immunology·M K GatelyR Chizzonite
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·S ChouaibF Mami-Chouaib
Aug 1, 1996·The Journal of Clinical Investigation·N BhardwajM V Feldman
Jan 1, 1997·Advances in Experimental Medicine and Biology·G Schuler, N Romani
Apr 29, 1998·Nature Biotechnology·S K NairE Gilboa
Dec 10, 1998·International Immunology·A SnijdersM L Kapsenberg
Feb 26, 1999·Journal of Immunological Methods·B ThurnerG Schuler
Jul 20, 1999·The Journal of Clinical Investigation·M V DhodapkarN Bhardwaj
Jul 23, 1999·Immunobiology·A D SantinG P Parham
Mar 23, 2000·The Journal of Clinical Investigation·M V DhodapkarN Bhardwaj
Nov 28, 2000·International Journal of Cancer. Journal International Du Cancer·A J BremersC Castelli
Jul 13, 2002·European Journal of Immunology·Anja LangenkampFederica Sallusto
Aug 1, 2002·Blood·Elke ScandellaMarcus Groettrup
Dec 4, 2002·Nature Reviews. Immunology·Antonio Lanzavecchia, Federica Sallusto
Dec 13, 2002·Vaccine·Andrew W LeeNina Bhardwaj
Jun 27, 2003·Cancer Immunology, Immunotherapy : CII·Dorian McIlroy, Marc Gregoire
Sep 6, 2003·Journal of Immunological Methods·Urska RepnikMatjaz Jeras
Dec 4, 2003·Nature Reviews. Immunology·Martien L Kapsenberg
May 4, 2004·Nature Medicine·Carl G FigdorCornelis J M Melief
Jul 6, 2004·Journal of Immunotherapy·Keiji ShimizuSuyu Shu
Apr 13, 2005·International Immunology·Detlef DieckmannGerold Schuler
Apr 26, 2005·Journal of Immunological Methods·Thomas G BergerGerold Schuler
Jun 27, 2006·Journal of Immunotherapy·Constanze VoigtländerManfred B Lutz